标题
Development of Human Carbonic Anhydrase II Heterobifunctional Degraders
作者
关键词
-
出版物
Journal of Medicinal Chemistry
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2023-02-04
DOI
10.1021/acs.jmedchem.2c01843
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).
- (2022) Xin Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Developing Metal-Binding Isosteres of 8-Hydroxyquinoline as Metalloenzyme Inhibitor Scaffolds
- (2022) Hyeonglim Seo et al. INORGANIC CHEMISTRY
- Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells
- (2022) Joshua P. Smalley et al. JOURNAL OF MEDICINAL CHEMISTRY
- ARV-471, an estrogen receptor (ER) PROTACdegrader, combined with palbociclib in advanced ER+/human epidermal growth factor receptor 2–negative (HER2-) breast cancer: Phase 1b cohort (part C) of a phase 1/2 study.
- (2022) Erika P. Hamilton et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutant-selective degradation by BRAF-targeting PROTACs
- (2021) Shanique Alabi et al. Nature Communications
- A single–cell type transcriptomics map of human tissues
- (2021) Max Karlsson et al. Science Advances
- PROTAC Technology: Opportunities and Challenges
- (2020) Hongying Gao et al. ACS Medicinal Chemistry Letters
- Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action
- (2020) Alessandro Bonardi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
- (2020) Chandra B. Mishra et al. MEDICINAL RESEARCH REVIEWS
- Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
- (2020) Tao Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Improved Accuracy for Modeling PROTAC-Mediated Ternary Complex Formation and Targeted Protein Degradation via New In Silico Methodologies
- (2020) Michael L. Drummond et al. Journal of Chemical Information and Modeling
- A chemical approach for global protein knockdown from mice to non-human primates
- (2019) Xiuyun Sun et al. Cell Discovery
- Carbonic anhydrases as disease markers
- (2019) Sabina Zamanova et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
- (2019) Hao Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery
- (2019) Alessio Nocentini et al. Expert Opinion on Drug Discovery
- Role of Carbonic Anhydrases and Inhibitors in Acid–Base Physiology: Insights from Mathematical Modeling
- (2019) Occhipinti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SAR Exploration of Tight Binding Inhibitors of Influenza Virus PA Endonuclease
- (2019) Cy V. Credille et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of New 1,1′-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II Inhibitors
- (2019) Giuseppe La Regina et al. ACS Medicinal Chemistry Letters
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A surface proton antenna in carbonic anhydrase II supports lactate transport in cancer cells
- (2018) Sina Ibne Noor et al. eLife
- Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach
- (2018) Zuni I. Bassi et al. ACS Chemical Biology
- Principles of Ubiquitin-Dependent Signaling
- (2018) Eugene Oh et al. Annual Review of Cell and Developmental Biology
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- A supramolecular dissociation strategy for protein sensing
- (2015) Hui Wang et al. CHEMICAL COMMUNICATIONS
- Probing the ‘bipolar’ nature of the carbonic anhydrase active site: Aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms
- (2015) Mikhail Krasavin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Activity and distribution of intracellular carbonic anhydrase II and their effects on the transport activity of anion exchanger AE1/SLC4A1
- (2013) Samer Al-Samir et al. JOURNAL OF PHYSIOLOGY-LONDON
- A Comprehensive Mathematical Model for Three-Body Binding Equilibria
- (2013) Eugene F. Douglass et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structure, function and applications of carbonic anhydrase isozymes
- (2012) Md. Imtaiyaz Hassan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structural annotation of human carbonic anhydrases
- (2012) Mayank Aggarwal et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Glaucoma
- (2011) Harry A Quigley LANCET
- Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II
- (2011) H. M. Becker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of linker length on the activity of PROTACs
- (2010) Kedra Cyrus et al. Molecular BioSystems
- Carbonic Anhydrase as a Model for Biophysical and Physical-Organic Studies of Proteins and Protein−Ligand Binding
- (2008) Vijay M. Krishnamurthy et al. CHEMICAL REVIEWS
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started